151 related articles for article (PubMed ID: 36006553)
1. Efficacy of desferrioxamine mesylate in intracerebral hematoma: a systemic review and meta-analysis.
Zhao K; Li J; Zhang Q; Yang M
Neurol Sci; 2022 Dec; 43(12):6771-6782. PubMed ID: 36006553
[TBL] [Abstract][Full Text] [Related]
2. Brain edema after intracerebral hemorrhage in rats: the role of iron overload and aquaporin 4.
Qing WG; Dong YQ; Ping TQ; Lai LG; Fang LD; Min HW; Xia L; Heng PY
J Neurosurg; 2009 Mar; 110(3):462-8. PubMed ID: 19025353
[TBL] [Abstract][Full Text] [Related]
3. Effects of Deferoxamine Mesylate on Hematoma and Perihematoma Edema after Traumatic Intracerebral Hemorrhage.
Yu J; Yuan Q; Sun YR; Wu X; Du ZY; Li ZQ; Wu XH; Zhou LF; Wu G; Hu J
J Neurotrauma; 2017 Oct; 34(19):2753-2759. PubMed ID: 28462672
[TBL] [Abstract][Full Text] [Related]
4. Perihematomal Edema Is Greater in the Presence of a Spot Sign but Does Not Predict Intracerebral Hematoma Expansion.
Rodriguez-Luna D; Stewart T; Dowlatshahi D; Kosior JC; Aviv RI; Molina CA; Silva Y; Dzialowski I; Lum C; Czlonkowska A; Boulanger JM; Kase CS; Gubitz G; Bhatia R; Padma V; Roy J; Subramaniam S; Hill MD; Demchuk AM;
Stroke; 2016 Feb; 47(2):350-5. PubMed ID: 26696644
[TBL] [Abstract][Full Text] [Related]
5. The clinical effect of deferoxamine mesylate on edema after intracerebral hemorrhage.
Yu Y; Zhao W; Zhu C; Kong Z; Xu Y; Liu G; Gao X
PLoS One; 2015; 10(4):e0122371. PubMed ID: 25875777
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of early intensive antihypertensive treatment on rebleeding and perihematomal edema in acute intracerebral hemorrhage.
Zang Y; Zhang C; Song Q; Zhang J; Li H; Zhang C; Feng S; Gu F
J Clin Hypertens (Greenwich); 2019 Sep; 21(9):1325-1331. PubMed ID: 31350828
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic aspiration-thrombolysis of intracerebral hemorrhage and its impact on perihematoma brain edema.
Carhuapoma JR; Barrett RJ; Keyl PM; Hanley DF; Johnson RR
Neurocrit Care; 2008; 8(3):322-9. PubMed ID: 18327659
[TBL] [Abstract][Full Text] [Related]
8. The effect of monascin on hematoma clearance and edema after intracerebral hemorrhage in rats.
Wang J; Wang G; Yi J; Xu Y; Duan S; Li T; Sun XG; Dong L
Brain Res Bull; 2017 Sep; 134():24-29. PubMed ID: 28655601
[TBL] [Abstract][Full Text] [Related]
9. Deferoxamine in intracerebral hemorrhage: Systematic review and meta-analysis.
Sun T; Zhao YY; Xiao QX; Wu M; Luo MY
Clin Neurol Neurosurg; 2023 Apr; 227():107634. PubMed ID: 36857886
[TBL] [Abstract][Full Text] [Related]
10. Chronological changes of perihematomal edema of human intracerebral hematoma.
Inaji M; Tomita H; Tone O; Tamaki M; Suzuki R; Ohno K
Acta Neurochir Suppl; 2003; 86():445-8. PubMed ID: 14753483
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of remote ischemic conditioning for the treatment of intracerebral hemorrhage: A proof-of-concept randomized controlled trial.
Zhao W; Jiang F; Li S; Liu G; Wu C; Wang Y; Ren C; Zhang J; Gu F; Zhang Q; Gao X; Gao Z; Song H; Ma Q; Ding Y; Ji X;
Int J Stroke; 2022 Apr; 17(4):425-433. PubMed ID: 33739197
[TBL] [Abstract][Full Text] [Related]
12. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage.
Nakamura T; Keep RF; Hua Y; Schallert T; Hoff JT; Xi G
Neurosurg Focus; 2003 Oct; 15(4):ECP4. PubMed ID: 15344903
[TBL] [Abstract][Full Text] [Related]
13. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage.
Nakamura T; Keep RF; Hua Y; Schallert T; Hoff JT; Xi G
J Neurosurg; 2004 Apr; 100(4):672-8. PubMed ID: 15070122
[TBL] [Abstract][Full Text] [Related]
14. High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods.
Yeatts SD; Palesch YY; Moy CS; Selim M
Neurocrit Care; 2013 Oct; 19(2):257-66. PubMed ID: 23943316
[TBL] [Abstract][Full Text] [Related]
15. Effects of statin and deferoxamine administration on neurological outcomes in a rat model of intracerebral hemorrhage.
Chun HJ; Kim DW; Yi HJ; Kim YS; Kim EH; Hwang SJ; Jwa CS; Lee YK; Ryou H
Neurol Sci; 2012 Apr; 33(2):289-96. PubMed ID: 21863269
[TBL] [Abstract][Full Text] [Related]
16. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage.
Selim M; Yeatts S; Goldstein JN; Gomes J; Greenberg S; Morgenstern LB; Schlaug G; Torbey M; Waldman B; Xi G; Palesch Y;
Stroke; 2011 Nov; 42(11):3067-74. PubMed ID: 21868742
[TBL] [Abstract][Full Text] [Related]
17. High Serum MiR-130a Levels Are Associated with Severe Perihematomal Edema and Predict Adverse Outcome in Acute ICH.
Wang MD; Wang Y; Xia YP; Dai JW; Gao L; Wang SQ; Wang HJ; Mao L; Li M; Yu SM; Tu Y; He QW; Zhang GP; Wang L; Xu GZ; Xu HB; Zhu LQ; Hu B
Mol Neurobiol; 2016 Mar; 53(2):1310-1321. PubMed ID: 25631713
[TBL] [Abstract][Full Text] [Related]
18. Systemic inflammation status at admission affects the outcome of intracerebral hemorrhage by increasing perihematomal edema but not the hematoma growth.
Fonseca S; Costa F; Seabra M; Dias R; Soares A; Dias C; Azevedo E; Castro P
Acta Neurol Belg; 2021 Jun; 121(3):649-659. PubMed ID: 31912444
[TBL] [Abstract][Full Text] [Related]
19. The combination of deferoxamine and minocycline strengthens neuroprotective effect on acute intracerebral hemorrhage in rats.
Li Z; Liu Y; Wei R; Khan S; Xue M; Yong VW
Neurol Res; 2021 Oct; 43(10):854-864. PubMed ID: 34107863
[No Abstract] [Full Text] [Related]
20. Perihematoma cerebral blood flow is unaffected by statin use in acute intracerebral hemorrhage patients.
Gioia LC; Kate M; McCourt R; Gould B; Coutts SB; Dowlatshahi D; Asdaghi N; Jeerakathil T; Hill MD; Demchuk AM; Buck B; Emery D; Shuaib A; Butcher K;
J Cereb Blood Flow Metab; 2015 Jul; 35(7):1175-80. PubMed ID: 25757757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
